IPAMORELIN

Ipamorelin is a selective growth hormone secretagogue and GHRP-3 analog studied for its pituitary GH release activity with high receptor specificity. Unlike earlier GHRPs, ipamorelin research demonstrates minimal elevation of cortisol or prolactin, making it one of the most selective and well-characterized GHRPs in the growth hormone secretagogue class.

Mechanism of Action

•        Binds to ghrelin receptors (GHS-R1a) on anterior pituitary somatotrophs, studied for selective GH secretion stimulation.

•        Research indicates minimal impact on cortisol, ACTH, or prolactin release, preserving hormonal specificity in study models.

•        Investigated for synergy with GHRH analogs (CJC-1295, sermorelin) through complementary receptor pathway activation.

•        Studies show downstream IGF-1 elevation, supporting muscle protein synthesis, fat metabolism, and tissue repair biology.

Research Areas

•        GH biology and somatotropic axis research.

•        Body composition research including muscle gain and fat reduction models.

•        Post-exercise recovery and injury healing biology.

•        Sleep quality research through GH nocturnal pulse biology.

•        Metabolic health and energy homeostasis studies.

Presentation and Storage

Supplied as a lyophilized powder in a sealed vial containing 10mg of ipamorelin. Reconstitute with bacteriostatic water for laboratory use. Store at -20C.